Ann Intern Med:乳房大、射片多,增加辐射相关乳腺癌风险

2016-01-12 Mechront 译 MedSci原创

从50岁开始每两年进行一次乳房钼靶检查可降低放射线暴露导致的乳腺癌风险。更大的乳房或隆乳术女性因为辐射的频率和剂量,乳腺癌发病率和死亡率风险更高。该篇发表在内科医学年鉴上的建模研究或会用于更新临床实践建议。重复的数字化乳腺钼靶摄影检查使女性暴露于电离辐射,会增加乳腺癌风险。研究者使用了电脑建模,根据女性筛查频率和剂量的变化,评估数字乳腺X线摄影术中辐射诱发的乳腺癌发生率和死亡率。研究者发现,每年进

从50岁开始每两年进行一次乳房钼靶检查可降低放射线暴露导致的乳腺癌风险。更大的乳房或隆乳术女性因为辐射的频率和剂量较多,乳腺癌发病率和死亡率风险更高。该篇发表在内科医学年鉴上的建模研究或会用于更新临床实践建议。

重复的数字化乳腺钼靶摄影检查使女性暴露于电离辐射,会增加乳腺癌风险。研究者使用了电脑建模,根据女性筛查频率和剂量的变化,评估数字乳腺X线摄影术中辐射诱发的乳腺癌发生率和死亡率。研究者发现,每年进行乳腺钼靶筛查的100000名40-74岁女性中有125例乳腺癌患者和16例死亡,但因为乳腺癌发现的早,也避免了968例死亡。乳房更大或隆胸的女性会受到高于平均辐射剂量的暴露,从而因射线暴露导致的乳腺癌风险增加。年轻时开始开始接受每年筛查也与增加风险。

虽然辐射诱发的乳腺癌发生率与乳腺癌死亡人数相比是非常小的一部分,但是也不能忽视。研究者称,在50岁之前女性开始每年一次的筛查过程中,乳房更大或隆胸的女性其辐射介导的乳腺癌风险是小或正常大小乳房女性的两倍。

原始出处:

Diana L. Miglioretti, PhD; Jane Lange, et al, Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study,  Annals of Internal Medicine, doi:10.7326/M15-1241, published online 12 January 2016.

Biennial mammography screening starting at age 50 may decrease risk for radiation-induced breast cancer


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2061507, encodeId=fd53206150e70, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Oct 08 00:28:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770244, encodeId=69f61e702441e, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jun 04 08:28:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72590, encodeId=c17ee259036, content=学习了要权衡利害, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:58:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349313, encodeId=deb51349313d9, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Jan 14 13:28:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606805, encodeId=006516068054a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jan 14 13:28:00 CST 2016, time=2016-01-14, status=1, ipAttribution=)]
    2016-10-08 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2061507, encodeId=fd53206150e70, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Oct 08 00:28:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770244, encodeId=69f61e702441e, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jun 04 08:28:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72590, encodeId=c17ee259036, content=学习了要权衡利害, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:58:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349313, encodeId=deb51349313d9, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Jan 14 13:28:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606805, encodeId=006516068054a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jan 14 13:28:00 CST 2016, time=2016-01-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2061507, encodeId=fd53206150e70, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Oct 08 00:28:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770244, encodeId=69f61e702441e, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jun 04 08:28:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72590, encodeId=c17ee259036, content=学习了要权衡利害, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:58:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349313, encodeId=deb51349313d9, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Jan 14 13:28:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606805, encodeId=006516068054a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jan 14 13:28:00 CST 2016, time=2016-01-14, status=1, ipAttribution=)]
    2016-03-22 Gsurgeon

    学习了要权衡利害

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2061507, encodeId=fd53206150e70, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Oct 08 00:28:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770244, encodeId=69f61e702441e, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jun 04 08:28:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72590, encodeId=c17ee259036, content=学习了要权衡利害, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:58:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349313, encodeId=deb51349313d9, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Jan 14 13:28:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606805, encodeId=006516068054a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jan 14 13:28:00 CST 2016, time=2016-01-14, status=1, ipAttribution=)]
    2016-01-14 jiyangfei
  5. [GetPortalCommentsPageByObjectIdResponse(id=2061507, encodeId=fd53206150e70, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Oct 08 00:28:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770244, encodeId=69f61e702441e, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jun 04 08:28:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72590, encodeId=c17ee259036, content=学习了要权衡利害, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:58:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349313, encodeId=deb51349313d9, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Jan 14 13:28:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606805, encodeId=006516068054a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jan 14 13:28:00 CST 2016, time=2016-01-14, status=1, ipAttribution=)]

相关资讯

Eur Radiol:钼靶乳腺密度低的乳腺癌可能预后不佳

芬兰东部大学最近的一项研究结果指出,非常低的钼靶乳腺密度(MBD)预兆着乳腺癌预后恶化。报道称,钼靶乳腺密度较低的乳腺癌患者,其无病生存期以及总生存期均较钼靶乳腺密度较高的短。乳房组织密度越低,意味着乳房组织内纤维腺体组织比脂肪组织少越多。在未来的临床实践中,这些发现可能为乳腺癌预后的评估和治疗计划的制定提供重要的依据。这项研究涉及了270名乳腺癌患者的研究在Kuopio大学医院进行,入组患者年龄

BMJ研究新闻:乳腺癌筛查中超声检查与钼靶X线检查的结果相似

据发表于Journal of the National Cancer Institute的一项新的研究表明,作为乳腺癌一个主要的筛查措施,超声检测与钼靶X线检测的乳腺癌检测率类似。该研究发现,超声检测可更好的检测浸润性且淋巴结阴性的乳腺癌,但是超声检测的假阳性结果也很高。

Lancet:乳腺癌筛查:钼靶+超声 vs 钼靶

目前临床上对乳腺癌筛查认可的检查方式是钼靶摄影,早期筛查可以减少乳腺癌死亡率,不过该方法在临床上对年轻女性或致密乳房的女性是不准确的。研究者进行了一项研究,调查在钼靶基础上,添加辅助超声对乳腺癌筛查的有效性。该研究在2007年7月-2011年3月间、23个地区、42个研究中心,纳入了年龄在40-49岁的无症状女性。参与者在过去5年没有任何癌症病史,且存活5年以上。按1:1将其随机分为钼靶+超声组和

Lancet Oncol:综合2D和3D钼靶筛查乳腺癌更具优势

采用3D乳房断层X线摄相或许能克服传统2D钼靶检查的不足,在发现乳腺癌病灶上更具优势。来自意大利Azienda省卫生服务公司的Stefano Ciatto等为了比较2D和3D钼靶检查在乳腺癌筛查方面的效果而设计了相关研究,并将其研究结果发表在Lancet Oncol 4月的在线期刊上。本研究名为“采用断层X线摄相或标准钼靶检查筛查研究”(STORM)——是一个前瞻性对比研究。在本研究中所纳入的受试